Form 8-K - Current report:
SEC Accession No. 0001078782-13-001301
Filing Date
2013-07-03
Accepted
2013-07-02 17:34:44
Documents
3
Period of Report
2013-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k070213_8k.htm 8-K 12901
2 EXHIBIT 99.1 PRESS RELEASE f8k070213_ex99z1.htm EX-99.1 5691
3 IMAGE f8k070213_ex99z1001.jpg GRAPHIC 11763
  Complete submission text file 0001078782-13-001301.txt   36388
Mailing Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095
Business Address 1656 REUNION AVENUE SUITE 250 SOUTH JORDAN UT 84095 801-446-8802
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445169 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 13950010
SIC: 2834 Pharmaceutical Preparations